| Views | |
|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 365 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response | 2 | 4 | 12 | 28 | 17 | 9 | 0 |
| Views | |
|---|---|
| 2019_Denker_etal.pdf | 161 |
